FDA guidance provides new details on diversity action plans for clinical studies

“All in Her Head” catalogs the history of medicine’s atrocities against women

Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.

Newly established Xavier Ochsner College of Medicine receives $5M from Bloomberg Philanthropies

Bloomberg Philanthropies announced a gift of $5 million in seed funding to support the creation of the Xavier Ochsner College of Medicine, a newly-established medical school in New Orleans founded by Xavier University of Louisiana and Ochsner Health.

August 09, 2024

Vol.50 No.32

Drugs & Targets

FDA approves Voranigo for grade 2 IDH-mutant glioma

FDA has approved Voranigo (vorasidenib), an isocitrate dehydrogenase-1 and isocitrate dehydrogenase-2 inhibitor, for the treatment of adult and pediatric patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery including biopsy, sub-total resection, or gross total resection.

August 09, 2024

Vol.50 No.32

Drugs & Targets

FDA approves Lymphir immunotherapy for r/r CTCL

FDA has approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of r/r cutaneous T-cell lymphoma after at least one prior systemic therapy.

August 09, 2024

Vol.50 No.32

Drugs & Targets

FDA grants de novo authorization for PGDx elio plasma focus Dx, a kitted, pan-solid tumor liquid biopsy test

Labcorp announced it has received de novo marketing authorization from FDA for PGDx elio plasma focus Dx—the industry’s first and only kitted, pan-solid tumor liquid biopsy test.

August 09, 2024

Vol.50 No.32

Health Equity

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

August 02, 2024

Vol.50 No.31

By Matthew Bin Han Ong

FDA guidance provides new details on diversity action plans for clinical studies

YOU MAY BE INTERESTED IN

“All in Her Head” catalogs the history of medicine’s atrocities against women

Newly established Xavier Ochsner College of Medicine receives $5M from Bloomberg Philanthropies

FDA approves Voranigo for grade 2 IDH-mutant glioma

FDA approves Lymphir immunotherapy for r/r CTCL

FDA grants de novo authorization for PGDx elio plasma focus Dx, a kitted, pan-solid tumor liquid biopsy test

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project

Renew today!

Subscriber content

Login

FDA guidance provides new details on diversity action plans for clinical studies

YOU MAY BE INTERESTED IN

“All in Her Head” catalogs the history of medicine’s atrocities against women

Newly established Xavier Ochsner College of Medicine receives $5M from Bloomberg Philanthropies

FDA approves Voranigo for grade 2 IDH-mutant glioma

FDA approves Lymphir immunotherapy for r/r CTCL

FDA grants de novo authorization for PGDx elio plasma focus Dx, a kitted, pan-solid tumor liquid biopsy test

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teamsWhy every cancer center needs a Cancer LAW Project

Login

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project